22-28687974-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007194.4(CHEK2):āc.1555C>Gā(p.Arg519Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000133 in 150,082 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_007194.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000133 AC: 2AN: 149966Hom.: 0 Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.95e-7 AC: 1AN: 1438278Hom.: 0 Cov.: 30 AF XY: 0.00000140 AC XY: 1AN XY: 716142
GnomAD4 genome AF: 0.0000133 AC: 2AN: 150082Hom.: 0 Cov.: 32 AF XY: 0.0000273 AC XY: 2AN XY: 73300
ClinVar
Submissions by phenotype
Familial cancer of breast Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.R519G variant (also known as c.1555C>G), located in coding exon 14 of the CHEK2 gene, results from a C to G substitution at nucleotide position 1555. The arginine at codon 519 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at